Biotechnology

AGC Biologics Expands Plasmid DNA Offering

SEATTLE, Dec. 11, 2019 /PRNewswire/ -- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals, is significantly expanding its CDMO services with plasmid DNA (pDNA) offerings from itsHeidelberg site in Germany. With the demand for pDNA growing rap...

2019-12-11 09:06 1899

Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma

SYDNEY, Dec. 11, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it's lead program, GDC-0084, has been selected to join GBM AGILE, an international, academic-led, multi-drug adaptive phase ...

2019-12-11 08:41 6286

Ascentage Pharma Releases Updated Data of its Novel BCR-ABL Inhibitor, HQP1351, in an Oral Presentation Nominated for "Best of ASH"

SUZHOU, China and ROCKVILLE, Md., Dec. 11, 2019 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the updated results ...

2019-12-11 08:00 11984

Publication of First In-Human Data Reveals Safety & Efficacy of Tigilanol Tiglate in Solid Tumours

* First in-human Clinical Phase I study of intratumoural tigilanol tiglate (EBC-46) has been published in The Lancet's EBioMedicine journal; * An efficacious dose was achieved and a Maximum Tolerated Dose (MTD) was not reached, indicating tigilanol tiglate tolerability in humans; * Promising...

2019-12-09 21:01 1295

PRC NHC Issues New Policy on Cord Blood Banks, Implementation Rules To Be Provided

HONG KONG, Dec. 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today reported thatChina's National Health Commission ("NHC") ...

2019-12-06 20:00 15194

Global Cord Blood Corporation Announces Results of 2019 Annual General Meeting

HONG KONG, Dec. 5, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2019 Annual Gene...

2019-12-05 21:30 13214

Hummingbird Bioscience Raises US$19 Million in Series B Financing

SINGAPORE, Dec. 5, 2019 /PRNewswire/ -- Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery and development of new breakthrough precision antibody therapeutics for difficult-to-treat conditions, today announced that it has raisedUS$19 million in a Series B finan...

2019-12-05 10:00 1742

Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine

Newly updated and expanded NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic clarify who should be tested for cancer-causing genetic mutations Experts caution about risks of direct-to-consumer genetic testing and stress the importance of genetic counselin...

2019-12-04 22:01 882

PathogenDx Lauded by Frost & Sullivan for Its Game-changing DNA-based Multiplex Microarray Technology

PathogenDx's breakthrough technology shifts the pathogen detection paradigm from microbial to molecular testing through its microarray assays, namely Detect X, EnviroX, and QuantX SANTA CLARA, California, Dec. 3, 2019 /PRNewswire/ -- Based on its recent analysis of the global microbial DNA testin...

2019-12-03 22:00 1253

Gowan Company Announces Acquisition of Two New Active Ingredients, Fenamidone and Pencycuron, from Bayer AG

HARPENDEN, England, Dec. 3, 2019 /PRNewswire/ -- Gowan Crop Protection Limited, an affiliate of Gowan Company, L.L.C., announced today that it has entered into agreements with Bayer AG to acquire  rights to the active ingredients Fenamidone and Pencycuron.  The acquisition includes product regist...

2019-12-03 01:00 1266

CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset

* The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB * CMAB will provide a full range of development and manufacturing services for Fapon Biopharma's biologic drug project...

2019-12-02 18:28 2295

Tyvyt (Sintilimab Injection), an Innovative PD-1 Inhibitor Jointly Developed by Innovent and Lilly, is Included in the New Catalogue of National Reimbursement Drug List (NRDL)

SUZHOU, China, Nov. 28, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today jointly announced...

2019-11-28 12:10 4063

Golden Meditech Announces FY2019/2020 Interim Results

Revenue Fluctuated Amidst the Challenging Market Conditions Significant Increase in Revenue Noted at Beijing Sunbow Obstetrics & Gynecology Hospital HONG KONG, Nov. 27, 2019 /PRNewswire/ -- For the Six Months Ended 30 September 2019 (HK$'000) 2018 (HK$'000) Change (%) Revenue 157,2...

2019-11-27 18:52 4739

Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2020

HONG KONG, Nov. 27, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for...

2019-11-27 05:16 11126

New Study by TauRx Shows a Minimum Dose of Hydromethylthionine Could Slow Cognitive Decline and Brain Atrophy in Mild-to-moderate Alzheimer's Disease

ABERDEEN, Scotland and SINGAPORE, Nov. 27, 2019 /PRNewswire/ -- In a paper published in today's online issue of theJournal of Alzheimer's Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels ...

2019-11-27 02:31 1426

Japan and Singapore Grant CRISPR Patents to Merck

- Merck now holds 22 CRISPR-related patents worldwide across nine different geographies - Patents cover Paired Cas9 Nickase CRISPR genome-editing technology to advance gene therapy and research DARMSTADT, Germany, Nov. 26, 2019 /PRNewswire/ -- Merck, a leading science and technology company, to...

2019-11-26 21:00 1848

Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZeneca

* Heart failure is a global pandemic with an estimated 64.3 million cases worldwide in 2017, costing overUS$100B per year * Drug developers currently lack effective humanized models for preclinical testing of targeted drug candidates in heart failure with preserved ejection fraction * The c...

2019-11-26 16:31 2162

USD 10 million transaction generated at Asia Agri-Tech Expo & Forum 2019 concluded on 2 November

TAIPEI, Nov. 25, 2019 /PRNewswire/ -- Taiwan premier agricultural international exhibition, Asia Agri-Tech Expo & Forum 2019, has concluded in November at Taipei Nangang Exhibition Center, Hall 1. Co-located with Aquaculture Taiwan and Livestock Taiwan, the triple show attracted more than 25,000 ...

2019-11-25 15:58 3072

WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland

DUNDALK, Ireland, Nov. 23, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development, and manufacturing, announced that its subsidiary WuXi Vaccines, engaged in ...

2019-11-23 01:55 4519

Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2020 Financial Results

HONG KONG, Nov. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financia...

2019-11-21 20:00 5769
1 ... 157158159160161162163 ... 168